Hydromer, Inc. Announces Preliminary Financial Results for Q2 2025

Hydromer, Inc. (OTC: HYDI), a pioneer in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices, has released its preliminary, unaudited financial results for the quarter ended June 30, 2025. The company reported a revenue of $0.94 million, marking a 14% increase from the $0.82 million recorded in the second quarter of 2024. However, Hydromer faced a net loss of $38,000 during the same period, attributed to legal and professional matters, alongside expenses related to facility and equipment upgrades.

Michael E. Torti, CEO of Hydromer, emphasized the company's resilience and strategic investments aimed at fostering long-term growth. 'The increase in revenue year-over-year underscores the strength of our customer relationships and the value of our coating technologies in the medical device sector,' Torti stated. He further highlighted that the expenses impacting profitability are viewed as strategic investments necessary for accelerating innovation, expanding market reach, and enhancing financial performance in future quarters.

Hydromer's commitment to innovation and operational efficiency remains unwavering. The company continues to focus on developing its high-value product pipeline, establishing new partnerships, and maintaining disciplined execution. With over 44 years of expertise in surface modification and coating solutions, Hydromer is poised to strengthen its position in the global market, serving industries across the United States, Europe, and Asia-Pacific.

The preliminary financial results are subject to the completion of Hydromer's 2025 year-end financial reporting processes, including reviews, audit, and potential adjustments. For more information on Hydromer's technologies and services, visit https://www.hydromer.com.

This press release contains forward-looking statements based on current expectations and involves risks and uncertainties that could cause actual results to differ materially. Hydromer undertakes no obligation to update these statements, except as required by law.